Ellen Goldberg
Director/Board Member bei CASTLE BIOSCIENCES, INC.
Vermögen: 210 536 $ am 31.03.2024
Profil
Ellen Goldberg is an Independent Director at Castle Biosciences, Inc. She previously worked as the Vice President-Marketing at Crescendo Bioscience LLC from 2009 to 2011.
Ms. Goldberg holds a graduate degree and an MBA from Stanford University.
She also has an undergraduate degree from Yale University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CASTLE BIOSCIENCES, INC.
0,03% | 14.07.2023 | 9 505 ( 0,03% ) | 210 536 $ | 31.03.2024 |
Aktive Positionen von Ellen Goldberg
| Unternehmen | Position | Beginn |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Director/Board Member | 16.07.2021 |
Ehemalige bekannte Positionen von Ellen Goldberg
| Unternehmen | Position | Ende |
|---|---|---|
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Sales & Marketing | 01.01.2011 |
Ausbildung von Ellen Goldberg
| Stanford University | Graduate Degree |
| Yale University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CASTLE BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |
